Year-end Sale % OFF 
Abstract
Purpose.To present a clinical case of leprosy exacerbation on the background of ongoing therapy.
 Materials and methods.A 52-year-old patient with a diagnosis of "lepromatous (cutaneous) leprosy, leprosy LL" (multi-bacterial leprosy, lepromatous form, active stage), has an exacerbation in the form of nodular erythema at 3.5 years after the start of treatment. Due to the exacerbation of the leprosy process, dexamethasone therapy was performed intravenously in a dose of 4 mg/ml 3.0 ml + 0.9% NaCl 200.0 ml daily No. 10.
 Results. An exacerbation was diagnosed leprosy nodular erythema. The prescription of adequate therapy led to a complete regression of clinical manifestations.
 Conclusion.The described case is presented in connection with the rarity of this dermatosis.
Highlights
State Research Center of Dermatovenereology and Cosmetology, Ministry of Health of the Russian Federation Korolenko str., 3, bldg 6, Moscow, 107076, Russia
The prescription of adequate therapy led to a complete regression of clinical manifestations
The described case is presented in connection with the rarity of this dermatosis
Summary
ФГБУ «Государственный научный центр дерматовенерологии и косметологии» Минздрава России 107076, Россия, г. Представить клинический случай обострения лепры на фоне проводимой терапии. Больная 52 лет, с диагнозом «лепроматозная лепра, лепра LL» (лепра многобактериальная, лепроматозная форма, активная стадия), через 3,5 года после начала лечения развилось обострение в виде узловатой эритемы. По поводу обострения лепрозного процесса проведена терапия дексаметазоном внутривенно капельно в дозе 4 мг/мл — 3,0 мл + 0,9% раствор NaCl 200,0 мл ежедневно No 10. Назначение адекватной терапии привело к полному регрессу клинических проявлений. Описанный случай представлен в связи с редкостью данного дерматоза. Ключевые слова: лепра, обострение, лепрозная узловатая эритема. Для цитирования: Семенова В.Г., Макарова Л.Л., Карамова А.Э. Вестник дерматологии и венерологии. 2020; 96 (3): 68–74 Vestnik Dermatologii i Venerologii. 2020; 96 (3): 68–74
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
